Report details COVID-19 drug shortages—and solutions

In the newest "COVID-19: The CIDRAP Viewpoint" report from the Center for Infectious Disease Research and Policy (CIDRAP), researchers lay out not only how the US drug supply chain has been vulnerable for years, but how those vulnerabilities are exacerbated by the COVID-19 pandemic. Read more about it on the CIDRAP website.